Codice QR

Targeting NLRP3 inhibits AML progression by inducing PERK/eIF2-mediated apoptosis

Abstract Background Acute myeloid leukemia (AML) is characterized by the abnormal proliferation of myeloid precursor cells and presents significant challenges in treatment due to its heterogeneity. Recently, the NLRP3 inflammasome has emerged as a potential contributor to AML pathogenesis, although...

Descrizione completa

Salvato in:
Autori principali: Michela Luciano, Helene Sieberer, Peter W. Krenn, Hieu-Hoa Dang, Julia Vetter, Theresa Neuper, Diana Amend, Constantin Blöchl, Christian X. Weichenberger, Anna Eglseer, Michael S. Unger, Ancuela Andosch, Philip Steiner, Daniel Neureiter, Renate Bauer, Laura Hummer, Suzana Tesanovic, Stephanie Binder, Dominik P. Elmer, Helen Strandt, Susanne Schaller, Dirk Strunk, Lisa Pleyer, Richard Greil, Stephan Winkler, Tanja N. Hartmann, Dirk Schmidt-Arras, Christian G. Huber, Fritz Aberger, Jutta Horejs-Hoeck
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMC 2024-09-01
Serie:Cell Communication and Signaling
Soggetti:
Acute myeloid leukemia
Apoptosis
eIF2α, NLRP3
PERK
Accesso online:https://doi.org/10.1186/s12964-024-01777-6
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi